U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2019
334
Substance Class Protein
Created
by admin
on Mon Mar 31 22:24:14 GMT 2025
Edited
by admin
on Mon Mar 31 22:24:14 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type SCFV
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
XSZ53G39H5
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
BROLUCIZUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
brolucizumab [INN]
Preferred Name English
ESBA-1008
Code English
Brolucizumab [WHO-DD]
Common Name English
RTH-258
Code English
RTH258
Code English
BROLUCIZUMAB [JAN]
Common Name English
IMMUNOGLOBULIN, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR A) (HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL ESBA1008 SCFV FRAGMENT)
Common Name English
BROLUCIZUMAB [USAN]
Common Name English
ESBA1008
Code English
BROLUCIZUMAB [MI]
Common Name English
Code System Code Type Description
USAN
DE-66
Created by admin on Mon Mar 31 22:24:14 GMT 2025 , Edited by admin on Mon Mar 31 22:24:14 GMT 2025
PRIMARY
NCI_THESAURUS
C169818
Created by admin on Mon Mar 31 22:24:14 GMT 2025 , Edited by admin on Mon Mar 31 22:24:14 GMT 2025
PRIMARY
DAILYMED
XSZ53G39H5
Created by admin on Mon Mar 31 22:24:14 GMT 2025 , Edited by admin on Mon Mar 31 22:24:14 GMT 2025
PRIMARY
RXCUI
2204915
Created by admin on Mon Mar 31 22:24:14 GMT 2025 , Edited by admin on Mon Mar 31 22:24:14 GMT 2025
PRIMARY
MERCK INDEX
m12186
Created by admin on Mon Mar 31 22:24:14 GMT 2025 , Edited by admin on Mon Mar 31 22:24:14 GMT 2025
PRIMARY
DRUG CENTRAL
5363
Created by admin on Mon Mar 31 22:24:14 GMT 2025 , Edited by admin on Mon Mar 31 22:24:14 GMT 2025
PRIMARY
INN
10053
Created by admin on Mon Mar 31 22:24:14 GMT 2025 , Edited by admin on Mon Mar 31 22:24:14 GMT 2025
PRIMARY
LACTMED
Brolucizumab
Created by admin on Mon Mar 31 22:24:14 GMT 2025 , Edited by admin on Mon Mar 31 22:24:14 GMT 2025
PRIMARY
WIKIPEDIA
Brolucizumab
Created by admin on Mon Mar 31 22:24:14 GMT 2025 , Edited by admin on Mon Mar 31 22:24:14 GMT 2025
PRIMARY
EVMPD
SUB180753
Created by admin on Mon Mar 31 22:24:14 GMT 2025 , Edited by admin on Mon Mar 31 22:24:14 GMT 2025
PRIMARY
SMS_ID
100000166567
Created by admin on Mon Mar 31 22:24:14 GMT 2025 , Edited by admin on Mon Mar 31 22:24:14 GMT 2025
PRIMARY
ChEMBL
CHEMBL3707357
Created by admin on Mon Mar 31 22:24:14 GMT 2025 , Edited by admin on Mon Mar 31 22:24:14 GMT 2025
PRIMARY
CAS
1531589-13-5
Created by admin on Mon Mar 31 22:24:14 GMT 2025 , Edited by admin on Mon Mar 31 22:24:14 GMT 2025
PRIMARY
DRUG BANK
DB14864
Created by admin on Mon Mar 31 22:24:14 GMT 2025 , Edited by admin on Mon Mar 31 22:24:14 GMT 2025
PRIMARY
RXCUI
2204916
Created by admin on Mon Mar 31 22:24:14 GMT 2025 , Edited by admin on Mon Mar 31 22:24:14 GMT 2025
ALTERNATIVE
FDA UNII
XSZ53G39H5
Created by admin on Mon Mar 31 22:24:14 GMT 2025 , Edited by admin on Mon Mar 31 22:24:14 GMT 2025
PRIMARY
From To
1_24 1_89
1_154 1_228
Related Record Type Details
HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR A
TARGET -> INHIBITOR
BROLUCIZUMAB-DBLL
SUB_CONCEPT->SUBSTANCE
Related Record Type Details
BROLUCIZUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966